← FDA Drug Approvals (Drugs@FDA)

LOPINAVIR AND RITONAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2021-06-04

Drug application

FDA Application #

ANDA091677

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOPINAVIR AND RITONAVIR

Generic name

LOPINAVIR AND RITONAVIR

Active ingredients

LOPINAVIR; RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2021-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown